7th HIVPed workshop_presentations

Pediatric Treatment Cascade: What Do We Need to Reach “90-90-90” for Children
Dr. E. Abrams
TDF Use Across the Age Spectrum: From Fetus to Adolescent
Dr. A. Turkova
Debate: CD4 Assays Are No Longer Needed for Care of Children in Low-Resource Countries - PRO
Dr. T. Ruel
Debate: CD4 Assays Are No Longer Needed for Care of Children in Low-Resource Countries - CON
Dr. D. Gibb
Virologic Outcomes of Children Switched from Lopinavir/Ritonavir- to Efavirenz-Based Antiretroviral Treatment: a retrospective cohort study
Dr. K. Reichmuth
The effect of systemic exposure to efavirenz, sex and age on the risk of virological non-suppression in HIV-infected African children.
Dr. A. Bienczak
Lopinavir ritonavir (1:1 ratio) in the presence of rifampicin is not inferior to lopinavir ritonavir (4:1 ratio) in the absence of rifampicin in Human Immune Deficiency Virus (HIV) children. Interim analysis of an open label sequential non-randomized pharmakinetics study
Dr. M. Cotton
Durability of first-line antiretroviral therapy (ART) in children in the European Pregnancy and Paediatric HIV Cohort Collaboration (EPPICC)
Dr. R. Goodall
Efavirenz-based therapy may simplify antiretroviral LPV-based therapy initiated in HIV-1-infected children before the age of 2 in West-Africa: the MONOD trial ANRS 12206.
Dr. V. Leroy
Reasons for delayed ART initiation in children with HIV in South Africa
Dr. E. Abrams
Innovative Adherence Interventions for HIV-Infected Youth
Dr. R. Vreeman
Bridging Worlds: Perinatally-Infected Youth and Transition to Adult Care
Dr. C. Foster
Anxiety and depression in young people with perinatal HIV and their HIV-negative siblings
Dr. M. Le Prevost
Hepatitis B Treatment Response to TDF in 3TC-experienced Perinatally HIV-infected Adolescents
Dr. T. Puthanakit
Prevalence and Associated Factors of Nonalcoholic Fatty Liver Disease and Liver Fibrosis among Perinatally HIV-infected Asian Adolescents
Dr. T. Sudjaritruk
Week 48 safety and efficacy of a rilpivirine (TMC278)-based regimen in HIV-infected treatment-naïve adolescents: PAINT Phase II trial
Dr. P. Flynn
Second-line ART treatment and resistance outcomes of Asian children
Dr. A. Sohn
HIV testing at birth: potential benefits, risks and feasibility - Overview lecture on Pros and Cons
Dr. L. Mofenson
Debate: HIV-Exposed Uninfected Infants Require Lifelong Follow Up in All Settings - PRO - standpoint
Dr. J. Jao
Debate: HIV-Exposed Uninfected Infants Require Lifelong Follow Up in All Settings - CON - standpoint
Dr. T. Puthanakit
HIV exposed uninfected South African infants experience greater severity but not frequency of common infectious diseases than HIV unexposed uninfected infants
Dr. A. Slogrove
Perturbations in gut microbiome in HIV-exposed uninfected (HEU) infants are related to maternal microbiome and human milk oligosaccharides
Dr. L. Kuhn
The impact of adding a virological testing at birth to the existing WHO infant testing algorithm in the 21 Global Plan countries 
Dr. Mallampati
Effectiveness of conditional cash transfers to increase retention in care and adherence to PMTCT services: A randomized controlled trial
Dr. M. Yotebieng
In utero Tenofovir Exposure is Not Associated with Poor Fetal Long Bone Growth
Dr. J. Jao
Psychosocial factors in younger versus older HIV-infected pregnant women initiating antiretroviral therapy in Cape Town, South Africa
Dr. M. Wong
Controversies in TB Meningitis
Dr. K. Dooley
Hepatitis C virus Infection in Children with and without HIV - Epidemiology
Dr. C. Thorne
Hepatitis C virus infection in children with and without HIV - Treatment
Dr. G. Indolfi
Hearing Loss in HIV-Infected Children in Lilongwe, Malawi
Dr. S. Hrapcak
Lower immune response in HIV-positive girls to the quadrivalent human papillomavirus vaccine
Dr. J. Brophy
Changes in renal laboratory parameters and bone mineral density in treatment-naïve HIV-1-infected adolescents initiating E/C/F/TAF or E/C/F/TDF
Dr. N. Rakhmanina
Decreased bone mass in perinatally HIV-infected school-aged South African children on antiretrovirals
Dr. S. Shiau
Early cardio-pulmonary disease in children despite early ART - Evidence from CHER cohort
Dr. S. Innes
Computerized cognitive rehabilitation training can improve neuropsychological outcomes in rural school-age Ugandan children with HIV.
Dr. M. Boivin